Page 1

DIAMYD MEDICAL QUARTERLY REPORT 3 September 2020 - May 2021 Diamyd Medical AB ( publ ) , Fiscal year 2020/2021 PRODUCED DIAMY VIAL GMP PRODUCED DIAMYD MEDICAL VIAL INVESTIGATONAS STUDY DRUG AAWE ZINDA DENG Developing precision medicine therapies for type 1 diabetes Diamyd Medical's B - share is traded on Nasdaq First North Growth Market under the ticker DMYD B. Further information is available on https://www.diamyd.com Diamyd Medical AB ( publ ) Kungsgatan 29 ⚫ SE - 111 56 Stockholm ⚫ Phone 08-661 00 26 www.diamyd.com • info@diamyd.com